Literature DB >> 8517705

In vitro postantibiotic effects following multiple exposures of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli in pooled human cerebrospinal fluid and Mueller-Hinton broth.

J A Karlowsky1, G G Zhanel, R J Davidson, S R Zieroth, D J Hoban.   

Abstract

Multiple exposures with cefotaxime in either Mueller-Hinton broth or cerebrospinal fluid had no effect on killing or the duration of postantibiotic effect (PAE) in Escherichia coli strains tested. However, upon multiple exposures in Mueller-Hinton broth, ciprofloxacin and gentamicin PAEs significantly decreased with a concomitant reduction in bacterial killing. A reduction in bacterial killing following multiple ciprofloxacin and gentamicin exposures was also seen with cerebrospinal fluid; however, the PAE was maintained.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8517705      PMCID: PMC187920          DOI: 10.1128/AAC.37.5.1154

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

Review 1.  The postantibiotic effect: a review of in vitro and in vivo data.

Authors:  G G Zhanel; D J Hoban; G K Harding
Journal:  DICP       Date:  1991-02

2.  Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.

Authors:  B Kuenzi; C Segessenmann; A U Gerber
Journal:  J Antimicrob Chemother       Date:  1987-11       Impact factor: 5.790

Review 3.  Classification of cells in the cerebrospinal fluid. A review.

Authors:  A Guseo
Journal:  Eur Neurol       Date:  1977       Impact factor: 1.710

4.  Cerebrospinal fluid proteins in neurology.

Authors:  A Lowenthal; R Crols; E De Schutter; J Gheuens; D Karcher; M Noppe; A Tasnier
Journal:  Int Rev Neurobiol       Date:  1984       Impact factor: 3.230

Review 5.  Killing and regrowth of bacteria in vitro: a review.

Authors:  W A Craig; S C Ebert
Journal:  Scand J Infect Dis Suppl       Date:  1990

6.  Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus.

Authors:  R J Davidson; G G Zhanel; R Phillips; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

7.  Ionic binding, adaptive resistance and post-antibiotic effect of netilmicin and ciprofloxacin.

Authors:  I M Gould; K Milne; G Harvey; C Jason
Journal:  J Antimicrob Chemother       Date:  1991-06       Impact factor: 5.790

8.  Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time.

Authors:  P J McDonald; W A Craig; C M Kunin
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

9.  Influence of human urine on the in vitro activity and postantibiotic effect of ciprofloxacin against Escherichia coli.

Authors:  G G Zhanel; J A Karlowsky; R J Davidson; D J Hoban
Journal:  Chemotherapy       Date:  1991       Impact factor: 2.544

10.  Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli.

Authors:  G G Zhanel; J A Karlowsky; R J Davidson; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

  10 in total
  7 in total

1.  Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model.

Authors:  J G den Hollander; J W Mouton; M P van Goor; F P Vleggaar; H A Verbrugh
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

2.  Variation in postantibiotic effect of clindamycin against clinical isolates of Staphylococcus aureus and implications for dosing of patients with osteomyelitis.

Authors:  I B Xue; P G Davey; G Phillips
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

Review 3.  Basis of anti-infective therapy: pharmacokinetic-pharmacodynamic criteria and methodology for dual dosage individualisation.

Authors:  A Sánchez-Navarro; M M Sánchez Recio
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

4.  In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.

Authors:  Valentin Al Jalali; Robert Sauermann; Sabine Eberl; Markus Zeitlinger
Journal:  Infection       Date:  2019-02-06       Impact factor: 3.553

5.  Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro.

Authors:  M L Barclay; E J Begg; S T Chambers; D R Boswell
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

Review 6.  The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.

Authors:  J M Hyatt; P S McKinnon; G S Zimmer; J J Schentag
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

7.  Once-daily aminoglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa.

Authors:  J A Karlowsky; G G Zhanel; R J Davidson; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.